This inventor holds 24 USPTO granted patents, primarily in Pharmaceutical Chemistry. Top assignees: Smith Kline & French Laboratories Limited, Glaxo Group Limited, Boehringer Mannheim Gmbh. Active years: 1983-2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Letchworth, GB (1983 - 1994)
- Harlow, GB (1992 - 2013)
Company Filing History:
15 out of 362 
8 out of 1,169 
1 out of 1,164 
Years Active: 1983-2013
Areas of Expertise:
Title: David G Cooper: Pioneer in Psychopharmacology
Introduction
David G Cooper is an esteemed inventor based in Letchworth, GB, known for his significant contributions to the field of medical chemistry. With a remarkable portfolio of 24 patents, Cooper's innovations primarily focus on compounds that exhibit activity at the M1 receptor, which play a crucial role in treating various psychological conditions.
Latest Patents
Among his latest patents, Cooper has developed compounds described in the formula (I) that demonstrate potential therapeutic uses in medicine. These compounds, along with their salts and solvates, feature various substitutions for R, which include fluoro or other halogens, and structurally diverse counterparts like alkyls and alkoxy groups. The significance of these compounds lies in their potential applications against psychotic disorders and cognitive impairment, including Alzheimer's Disease. Furthermore, his patents disclose pharmaceutical compositions that comprise these innovative compounds, thereby paving the way for novel treatment methodologies.
Career Highlights
Cooper's career has been marked by affiliations with reputable establishments like Smith Kline & French Laboratories Limited and Glaxo Group Limited. His extensive experience in these companies has allowed him to contribute meaningfully to research and development in the pharmaceutical domain.
Collaborations
Throughout his professional journey, Cooper has collaborated with notable colleagues, including George S Sach and Ian Thomson Forbes. These partnerships have not only fueled innovation but have also led to the advancement of crucial pharmaceutical developments.
Conclusion
David G Cooper's work in research and development in the pharmaceutical realm exemplifies a deep commitment to addressing complex medical challenges. His innovative compounds and extensive patent portfolio highlight his role as a leading figure in psychopharmacology, ultimately contributing to improved therapies for mental health disorders.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile